|
|
||||||||
The Annals of Thoracic Surgery, Vol 56, 215-222, Copyright © 1993 by The Society of Thoracic Surgeons
CM Dyke, M Ding, AS Abd-Elfattah, K Loesser, RJ Dignan, AS Wechsler and DR Salter
Cardiopulmonary bypass causes a "euthyroid-sick" state characterized by low
levels of circulating triiodothyronine. Triiodothyronine supplementation in
this setting has been postulated to improve postischemic left ventricular
function by increasing the availability of myocardial high-energy
phosphates. These postulates have not been substantiated, however, using
load-independent parameters of left ventricular function and analysis of
high-energy phosphate metabolism. To test these hypotheses, 14 healthy pigs
(30 to 40 kg) were placed on cardiopulmonary bypass and instrumented with
left ventricular minor- axis ultrasonic crystals and micromanometer-tipped
pressure catheters. Hearts were subjected to 30 minutes of global,
normothermic ischemia. Triiodothyronine (0.1 mg/kg; n = 7) or placebo (n =
7) was administered in a random, investigator-blinded fashion at the
removal of the aortic cross-clamp and after 60 minutes of reperfusion.
Hemodynamic, metabolic, and ultrastructural data were obtained before
ischemia and after 30, 60, 90, and 120 minutes of reperfusion. By 90
minutes of reperfusion left ventricular contractility had returned to
preischemic levels in hearts supplemented with triiodothyronine, despite
postischemic myocardial adenosine triphosphate levels of 50% to 60% of
baseline in both groups. Ultrastructurally, the sarcoplasmic reticulum and
mitochondria were significantly better preserved in the group treated with
triiodothyronine. This study suggests that triiodothyronine supplementation
significantly enhances postischemic left ventricular functional recovery
and that this recovery is due to mechanisms other than enhanced
availability of myocardial high-energy phosphates.
ARTICLES
Effects of triiodothyronine supplementation after myocardial ischemia
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
This article has been cited by other articles:
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
M. Guden, B. Akpinar, E. Saggbas, I. Sanisoglu, E. Cakali, and O. Bayindir Effects of Intravenous Triiodothyronine During Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 219 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murai, Y. Katayama, T. Yamada, T. Imazeki, Y. Irie, H. Kiyama, Y. Sato, I. Hata, H. Yoshida, and M. Mukouyama Thyroid Hormone and Myocardial Metabolism After Heart Surgery in Dogs Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 13 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Klemperer, I. L. Klein, K. Ojamaa, R. E. Helm, M. Gomez, O. W. Isom, and K. H. Krieger Triiodothyronine Therapy Lowers the Incidence of Atrial Fibrillation After Cardiac Operations Ann. Thorac. Surg., May 1, 1996; 61(5): 1323 - 1327. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text] |
||||
![]() |
J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |